CLO25-072: A Multicenter, Randomized, Controlled, Non-Inferiority Study of Narlumosbart Compared With Denosumab in the Treatment of Bone Disease in Patients With Multiple Myeloma
Lists
Only you see this
Abstract
"CLO25-072: A Multicenter, Randomized, Controlled, Non-Inferiority Study of Narlumosbart Compared With Denosumab in the Treatment of Bone Disease in Patients With Multiple Myeloma" published on 28 Mar 2025 by National Comprehensive Cancer Network.
BibTeX
@article{huang2025clo,
author = {Honghui Huang and Fei Li and Yan Xu and Wenming Chen and Guangxun Gao and Zhongjun Xia and Xiaobing Huang and Jun Luo and Xiaoling Guo and Chunrui Li and Chunyan Sun and Baijun Fang and Fengyan Jin and Yongqian Jia and Shuhao Mei and Juan Du and Rong Zhan and Zhen Cai and Luqun Wang and Hongming Huang and Hongfeng Ge and Xiuhua Han and Jian Hou},
title = {{CLO25-072: A Multicenter, Randomized, Controlled, Non-Inferiority Study of Narlumosbart Compared With Denosumab in the Treatment of Bone Disease in Patients With Multiple Myeloma}},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2025},
doi = {10.6004/jnccn.2024.7215},
}Loading related content...